A. Sevinc Et Al. , "Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK.," 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , vol.30, Illinois, United States Of America, 2012
Sevinc, A. Et Al. 2012. Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK.. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).
Sevinc, A., TURNA, Z. H., Ozdogan, M., Buyukberber, S., Demir, G., Gokmen, E., ... Mandel, N. M.(2012). Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK. . 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America
Sevinc, Alper Et Al. "Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK.," 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2012
Sevinc, Alper Et Al. "Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK.." 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2012
Sevinc, A. Et Al. (2012) . "Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK.." 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={Alper Sevinc Et Al. }, title={Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK.}, congress name={48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2012}}